21.75
Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie
Real time breakdown of Enliven Therapeutics Inc. stock performanceJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
Heatmap analysis for Enliven Therapeutics Inc. and competitorsChart Signals & AI Enhanced Market Trend Forecasts - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Trading 8.1% Higher – Time to Buy? - Defense World
Tools to monitor Enliven Therapeutics Inc. recovery probabilityRecession Risk & Daily Profit Maximizing Tips - newser.com
How to read the order book for Enliven Therapeutics Inc.2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-15 02:57:52 - newser.com
Enliven Therapeutics Inc. recovery potential after sell off2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
What the charts say about Enliven Therapeutics Inc. todayShort Setup & Daily Volume Surge Trade Alerts - newser.com
Strategies to average down on Enliven Therapeutics Inc.July 2025 Patterns & Expert Curated Trade Setups - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Trade Exit Summary & Consistent Return Investment Signals - newser.com
Chart based exit strategy for Enliven Therapeutics Inc.July 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Trading 6.1% HigherHere's Why - MarketBeat
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat
Volatility clustering patterns for Enliven Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - newser.com
Is a relief rally coming for Enliven Therapeutics Inc. holdersWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Long term hold vs stop loss in Enliven Therapeutics Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Using Ichimoku Cloud for Enliven Therapeutics Inc. technicals2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Enliven Therapeutics COO Patel sells $133,992 in stock By Investing.com - Investing.com South Africa
Enliven Therapeutics COO Patel sells $133,992 in stock - Investing.com
Short interest data insights for Enliven Therapeutics Inc.Market Activity Report & Real-Time Volume Spike Alerts - newser.com
What moving averages say about Enliven Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - newser.com
Why retail investors favor Enliven Therapeutics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is now a turning point for Enliven Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com
Enliven Therapeutics stock falls after pricing capital raise of $200M via securities offering - MSN
Developing predictive dashboards with Enliven Therapeutics Inc. dataStop Loss & Weekly Sector Rotation Insights - newser.com
Will Enliven Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
Top chart patterns to watch in Enliven Therapeutics Inc.July 2025 Retail & Risk Managed Investment Signals - newser.com
Will Enliven Therapeutics Inc. stock recover after recent drop2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Benjamin Hohl Sells 3,250 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $81,000.00 in Stock - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):